Combination of organic compounds

Details for Australian Patent Application No. 2005282290 (hide)

Owner Novartis AG

Inventors Mercuri, Michele; Wang, Pei-Ran; Nevatia, Meenakshi; Maher, William; Chen, Hong

Agent Davies Collison Cave

Pub. Number AU-B-2005282290

PCT Pub. Number WO2006/029349

Priority 60/609,577 14.09.04 US; 60/689,738 10.06.05 US; 60/608,310 09.09.04 US

Filing date 8 September 2005

Wipo publication date 16 March 2006

Acceptance publication date 25 June 2009

International Classifications

A61P 25/30 (2006.01) Drugs for disorders of the nervous system

A61K 31/00 (2006.01)

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/522 (2006.01)

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

22 March 2007 PCT application entered the National Phase

  PCT publication WO2006/029349 Priority application(s): WO2006/029349

25 June 2009 Application Accepted

  Published as AU-B-2005282290

22 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005282292-Antiseptic compositions and methods of use

2005282269-Rotary separator and method